Stay Ahead of Compliance with Monthly Citation Updates


In your State Survey window and need a snapshot of your risks?

Survey Preparedness Report

One Time Fee
$79
  • Last 12 months of citation data in one tailored report
  • Pinpoint the tags driving penalties in facilities like yours
  • Jump to regulations and pathways used by surveyors
  • Access to your report within 2 hours of purchase
  • Easily share it with your team - no registration needed
Get Your Report Now →

Monthly citation updates straight to your inbox for ongoing preparation?

Monthly Citation Reports

$18.90 per month
  • Latest citation updates delivered monthly to your email
  • Citations organized by compliance areas
  • Shared automatically with your team, by area
  • Customizable for your state(s) of interest
  • Direct links to CMS documentation relevant parts
Learn more →

Save Hours of Work with AI-Powered Plan of Correction Writer


One-Time Fee

$29 per Plan of Correction
Volume discounts available – save up to 20%
  • Quickly search for approved POC from other facilities
  • Instant access
  • Intuitive interface
  • No recurring fees
  • Save hours of work
F0552
E

Failure to Obtain and Document Informed Consent for Psychotropic Medications

Mechanicsburg, Pennsylvania Survey Completed on 01-22-2026

Penalty

No penalty information released
tooltip icon
The penalty, as released by CMS, applies to the entire inspection this citation is part of, covering all citations and f-tags issued, not just this specific f-tag. For the complete original report, please refer to the 'Details' section.

Summary

The facility failed to ensure that residents were fully informed and provided consent for psychotropic medications, as evidenced by record reviews for two residents. One resident had diagnoses including major depressive disorder with psychotic features and generalized anxiety disorder and had physician orders for quetiapine and lorazepam, with a history of being on these types of medications for several months. The resident’s clinical record contained a Psychotropic Medication Treatment Consent form that incorrectly listed the treatment reason as Tracheotomy/Brain Damage, left the medication section blank, and was signed by the resident’s representative. The record did not contain documentation that the resident or representative had been educated on the risks, benefits, side effects, or other adverse reactions associated with the ordered antipsychotic and antianxiety medications. Another resident had diagnoses including schizoaffective disorder bipolar type, generalized anxiety disorder, and major depressive disorder, and had physician orders for olanzapine, buspirone, and escitalopram. This resident’s Psychotropic Medication Treatment Consent form had both the condition being treated and the medications being used left blank, although it was signed by the resident’s representative. The clinical record similarly lacked documentation that the resident or representative had been informed of the risks and benefits, including side effects and adverse reactions, of the antipsychotic, antianxiety, and antidepressant medications. During an interview, the NHA stated that the facility’s practice was to obtain a psychotropic consent at admission only and not to obtain additional consents, and that staff would review medication changes with representatives and document these discussions in progress notes; however, no such documentation was found for these two residents.

Long-term care team reviewing survey readiness and plan of correction

We Help Long-Term Care Teams Stay Survey-Ready

We process and analyze inspection reports and plan of correction using AI to extract insights and trends so providers can improve care quality and stay ahead of compliance risks.

Discover our solutions:

An unhandled error has occurred. Reload 🗙